Trademarkia Logo

Canada

C$
ENCELADUS BIO
SEARCHED

on 4 Oct 2024

Last Applicant/ Owned by

FIRSTLIGHT BIO INC.

Alexandria LaunchLabs, 14th Floor,430 East 29th StreetNew York NY 10016

US

Serial Number

2265314 filed on 12th May 2023

ENCELADUS BIO

Trademark usage description

pharmaceutical and biological preparations based on genome editing and engineering for use in human therapeutics. medical and scientific research inf Read More

Classification Information


Class [005]
Pharmaceutical and biological preparations based on genome editing and engineering for use in human therapeutics.


Classification kind code

12

Class [042]
Medical and scientific research information in the field of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; pharmaceutical research and development; pharmaceutical research services; providing medical research and scientific research information in the fields of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy.


Classification kind code

12

Mark Details


Serial Number

2265314

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 4th Oct 2024
Search Recorded
Submitted for opposition 20
on 4th Oct 2024
Examiner's First Report
Submitted for opposition 223
on 4th Oct 2024
Total Provisional Refusal
Submitted for opposition 256
on 22nd Apr 2024
Notification of Possible Opposition Sent
Submitted for opposition 257
on 22nd Jun 2023
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 21st Jun 2023
Formalized
Submitted for opposition 1
on 21st Jun 2023
Created
Submitted for opposition 228
on 12th May 2023
International Registration
Submitted for opposition 30
on 12th May 2023
Filed